Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1F 18 T807----1件: 127
2F-18----2件: 5, 127
3F-18 3F4AP----1件: 13
4F-18 AV 1451----1件: 5
5F-18 FDG----1件: 127
6F-18 FEDAA1106 (BAY85-8101)----1件: 13
7F-18 FPCIT----1件: 6
8F-A-F-A (FIASP-NovoRapid-FIASP-NovoRapid)----1件: 299
9F13CD----1件: 288
10F8IL10----2件: 46, 97
11F8VR----1件: 288
12FAB122----1件: 2
13FABRAZYME1件: Agalsidase beta1件: D03228 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
14Fabrazyme (agalsidase beta)1件: Agalsidase beta1件: D03228 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
15FABRAZYME - 35 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE ENDOVENOSA 1 FLACONCINO1件: Agalsidase beta1件: D03228 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
16Fabrazyme 35 mg1件: Agalsidase beta1件: D03228 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
17Fabrazyme 5 mg1件: Agalsidase beta1件: D03228 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
18FACTANE 200 IU/ml----1件: 288
19Factor VIII1件: Beroctocog alfa---1件: 288
20Factor VIII concentrate1件: Beroctocog alfa---1件: 288
21Factor von Willebrand1件: Von Willebrand factor human---1件: 288
22FACTOR X1件: Coagulation factor X human---1件: 288
23Factor XIII1件: Factor XIII (human)---3件: 51, 97, 288
24Factor XIII Concentrate (Human)1件: Factor XIII (human)---1件: 288
25Factor XIII Concentrate (Human), Pasteurized1件: Factor XIII (human)---1件: 288
26Faecal matter----1件: 97
27Faecal Microbiota Transplant----1件: 97
28Faecal microbiota transplantation----5件: 46, 84, 96, 97, 271
29Faecal sampling----1件: 46
30FAM Therapy----1件: 228
31FamC-1----1件: 2
32Famciclovir1件: Famciclovir1件: D00317 --1件: 13
33FAMOTIDINA1件: Famotidine1件: D00318 1件: HRH2 💬3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬1件: 61
34Famotidine1件: Famotidine1件: D00318 1件: HRH2 💬3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬6件: 6, 46, 86, 98, 107, 300
35Famotidine 20 MG1件: Famotidine1件: D00318 1件: HRH2 💬3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬1件: 86
36FAMPRIDINA1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
37FAMPRIDINE1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 13, 14
38Fampridine SR1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
39Fampridine-SR1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
40Fampridine-SR b.i.d. (Twice Daily)1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
41FAMPYRA1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 13, 14
42FAMPYRA - 10 MG - COMPRESSA A RILASCIO PROLUNGATO - USO ORALE - FLACONE (HDPE) 56 COMPRESSE (4 FLACONI DA 14)1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
43Fampyra 10 mg prolonged-release tablets2件: Dalfampridine,
Manganese citrate		1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
44Fampyra 10mg prolonged release tablets2件: Dalfampridine,
Manganese citrate		1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
45Fan beam CT scan----1件: 49
46Fang yi qing feng shi granule----1件: 46
47FANG(30)----1件: 46
48Fanhdi----1件: 288
49FANHDI 100 UI----1件: 288
50Fanhdi 100 UI FVIII-120 UI FVW----1件: 288
51FANHDI 25 UI----1件: 288
52Fanhdi 25 UI FVIII-30 UI FVW----1件: 288
53FANHDI 250UI*1F 250UI+F 10ML----1件: 288
54FANHDI 50 UI----1件: 288
55Fanhdi 50 UI FVIII-60 UI FVW----1件: 288
56FANHDI*INF FL 250UI+SIR SOLV+S----1件: 288
57FANHDI*INF FL 500UI+SIR SOLV+S----1件: 288
58FANHDI*INF FL1000UI+SIR SOLV+S----1件: 288
59FANHDI*INF FL250UI+SIR SOLV+S----1件: 288
60Fansidar (pyrimethamine and sulfadoxine)2件: Pyrimethamine,
Sulfadoxine		2件: D00488 ,
D00580 		--1件: 65
61Fasenra1件: Benralizumab1件: D09874 1件: IL5RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬5件: 44, 45, 98, 162, 299
62Faslodex1件: Fulvestrant1件: D01161 2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 49
63Fasudil1件: Fasudil1件: D07941 2件: ROCK1,
ROCK2 💬		23件: Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 2, 5, 7, 51
64Fasudil (WP-0512)1件: Fasudil1件: D07941 2件: ROCK1,
ROCK2 💬		23件: Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2
65FASUDIL HYDROCHLORIDE1件: Fasudil1件: D07941 2件: ROCK1,
ROCK2 💬		23件: Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2
66Fat diet----1件: 78
67Fatigue----1件: 13
68FAXE Kondi----1件: 257
69Faxe Kondi Free----1件: 257
70FB-101----1件: 6
71FB704A----1件: 46
72FBL-MTX----1件: 46
73FBS0701----1件: 284
74FBS0701 CAPSULE----1件: 284
75FBS0701/SSP004184----1件: 284
76FBX-101----1件: 19
77Fc- and CDR-modified humanised monoclonal antibody against C5----3件: 11, 62, 109
78FCM----2件: 63, 222
79FCN-159----1件: 34
80FCR001----1件: 51
81FCX-007 (dabocemagene autoficel----1件: 36
82FDC macitentan/tadalafil2件: Macitentan,
Tadalafil		2件: D02008 ,
D10135 		3件: EDNRA,
EDNRB,
PDE5A 💬		11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
83FDG----1件: 84
84FDG-PET----1件: 299
85FDL169----1件: 299
86FDL176----1件: 299
87FDL176 & FDL169 coadministration----1件: 299
88FE 992097----1件: 193
89FE 999301----2件: 96, 97
90Feburane----1件: 21
91Febuxostat1件: Febuxostat1件: D01206 1件: XDH 💬5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬3件: 2, 6, 13
92Fecal Microbial transplant----2件: 96, 97
93Fecal microbial transplant (FMT)----1件: 13
94Fecal Microbial Transplantation----2件: 96, 97
95Fecal Microbial Transplants----1件: 13
96Fecal microbiota----3件: 13, 96, 97
97Fecal microbiota capsule----1件: 97
98Fecal Microbiota Enema----1件: 97
99Fecal Microbiota Transplant----2件: 96, 97
100Fecal Microbiota Transplant (FMT)----2件: 96, 97
101Fecal microbiota transplantation----5件: 2, 66, 94, 96, 97
102Fecal Microbiota Transplantation (FMT)----2件: 96, 97
103Fecal Microbiota Transplantation (FMT) of FMP30 Donor Stool----1件: 13
104Fecal Microbiota Transplantation (FMT), OpenBiome----1件: 97
105Felzartamab1件: Felzartamab---1件: 66
106Femoston 1/10----1件: 13
107Femoston 2/10----1件: 13
108Fendrix1件: Hepatitis B Vaccine (Recombinant)---1件: 46
109Fendrix suspension for injection1件: Hepatitis B Vaccine (Recombinant)---1件: 46
110Fendrix suspension for injection Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed).1件: Hepatitis B Vaccine (Recombinant)---1件: 46
111FENEBRUTINIB1件: Fenebrutinib1件: D11457 1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 13
112Fenfluramina1件: Fenfluramine1件: D07945 4件: HTR2A,
HTR2B,
HTR2C,
SLC6A4 💬		6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬2件: 140, 144
113Fenfluramina Cloridrato1件: Fenfluramine1件: D07945 4件: HTR2A,
HTR2B,
HTR2C,
SLC6A4 💬		6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬2件: 140, 144
114FENFLURAMINE1件: Fenfluramine1件: D07945 4件: HTR2A,
HTR2B,
HTR2C,
SLC6A4 💬		6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬4件: 140, 144, 145, 149
115Fenfluramine HCl, DL-Fenfluramine, (±)-Fenfluramine1件: Fenfluramine1件: D07945 4件: HTR2A,
HTR2B,
HTR2C,
SLC6A4 💬		6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 144
116FENFLURAMINE HYDROCHLORIDE1件: Fenfluramine1件: D07945 4件: HTR2A,
HTR2B,
HTR2C,
SLC6A4 💬		6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬2件: 140, 144
117FENFLURAMINE HYDROCHLORIDE (colorless)1件: Fenfluramine1件: D07945 4件: HTR2A,
HTR2B,
HTR2C,
SLC6A4 💬		6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬2件: 140, 144
118FENFLURAMINE HYDROCHLORIDE (red)1件: Fenfluramine1件: D07945 4件: HTR2A,
HTR2B,
HTR2C,
SLC6A4 💬		6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 140
119Fengshigutong Capsule----1件: 271
120Fengshigutong Capsule plus Imrecoxib1件: Imrecoxib---1件: 271
121Fenilbutirato----1件: 2
122Fenofibrate1件: Fenofibrate1件: D00565 1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬5件: 8, 79, 93, 94, 265
123Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle)1件: Fenofibrate1件: D00565 1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93
124Fenretinide1件: Fenretinide1件: D04162 2件: RARA,
RARB 💬		8件: Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 299
125Fentanyl1件: Fentanyl2件: D00320 ,
D01399 		1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬4件: 46, 70, 215, 231
126Fentanyl (High Dose)1件: Fentanyl2件: D00320 ,
D01399 		1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 215
127Fentanyl (Low Dose)1件: Fentanyl2件: D00320 ,
D01399 		1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 215
128Fentanyl (Low Dose) + Dexmedetomidine2件: Dexmedetomidine,
Fentanyl		4件: D00320 ,
D00514 ,
D01205 ,
D01399 		4件: ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬		4件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215
129Fentanyl transdermal patch1件: Fentanyl2件: D00320 ,
D01399 		1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 46
130Feraheme1件: Ferumoxytol1件: D04177 --1件: 13
131Ferinject----2件: 86, 299
132Ferinject or CosmoFer----1件: 86
133Fermented oyster extract1件: Oyster---1件: 84
134Ferric Carboxy Maltose1件: Maltose1件: D00044 --1件: 96
135FERRIC CARBOXYMALTOSE1件: Ferric carboxymaltose1件: D08920 --4件: 86, 96, 97, 299
136Ferric Maltol1件: Ferric maltol1件: D10833 --1件: 96
137Ferricarboxymaltose----1件: 86
138Ferriprox1件: Deferiprone1件: D07416 --2件: 6, 120
139Ferriprox 500 mg1件: Deferiprone1件: D07416 --1件: 6
140FERRIPROX*100CPR RIV 500MG1件: Deferiprone1件: D07416 --1件: 120
141Ferrograd----1件: 46
142Ferrograd Folic Tablets----1件: 46
143Ferrous sulfate 325mg1件: Sulfate ion---1件: 299
144Ferrous sulphate----2件: 96, 97
145Ferrous sulphate 200mg oral tablet----1件: 227
146Ferrprox (Deferiprone)1件: Deferiprone1件: D07416 --1件: 6
147Ferulic acid1件: Ferulic acid---1件: 127
148Ferumoxytol1件: Ferumoxytol1件: D04177 --1件: 13
149Fesoterodine1件: Fesoterodine1件: D07226 2件: CHRM2,
CHRM3 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6
150Fetal porcine cells, Neurocell-PD----1件: 6
151Fetal surgery for MMC repair----1件: 118
152Fexinidazole1件: Fexinidazole1件: D11252 --1件: 65
153Fexofenadine1件: Fexofenadine2件: D00671 ,
D07958 		1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬2件: 13, 46
154FFP104----2件: 93, 96
155FG-3019----3件: 85, 113, 222
156FG-3019 10mg/mL in 10 mL vials----1件: 85
157Fibrate treatment----1件: 160
158Fibrin1件: Fibrin---1件: 96
159Fibrin glue injection in fistula1件: Fibrin---1件: 96
160Fibrinogen1件: Fibrinogen human---3件: 14, 65, 288
161Fibrinogen (coagulation factorI)1件: Fibrinogen human---1件: 65
162Fibrinogen concentrate1件: Fibrinogen human---1件: 14
163Fibrinogen Concentrate from Human Plasma1件: Fibrinogen human---1件: 65
164Fibroblasts----1件: 36
165Fibrogammin P----1件: 288
166Fibrogammin® 1250----1件: 51
167Fibrogammin® P----1件: 288
168Fibrogammin®P----1件: 288
169Fibrogammin®P, coagulation factor XIII concentrate (Human)1件: Factor XIII (human)---1件: 51
170Fibroscan----2件: 93, 171
171Fibrovein----1件: 279
172Fibrovein 3%----1件: 279
173Fig1件: Fig---1件: 2
174Filamentous haemagglutinin1件: Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)---1件: 46
175Filamentous haemagglutinin adsorbed1件: Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)---1件: 46
176FILGOTINIB1件: Filgotinib1件: D10871 1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬6件: 46, 53, 96, 97, 222, 271
177Filgotinib 200mg/day1件: Filgotinib1件: D10871 1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46
178Filgrastim1件: Filgrastim1件: D03235 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬28件: 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331
179Filgrastim (G-CSF)1件: Filgrastim1件: D03235 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 331
180Filgrastim Hexal1件: Filgrastim1件: D03235 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65
181Filgrastim, Alemtuzumab2件: Alemtuzumab,
Filgrastim		2件: D02802 ,
D03235 		2件: CD52,
CSF3R 💬		6件: , Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65
182Film-coated tablet----1件: 97
183Finamine tablets----1件: 6
184Finasteride1件: Finasteride1件: D00321 1件: SRD5A2 💬3件: Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬1件: 6
185Finely ground flaxseed powder1件: Flax seed---1件: 299
186Fingolimob----1件: 13
187Fingolimob (FTY)----1件: 13
188FINGOLIMOD1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 14, 156
189Fingolimod (FTY720)1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 156
190Fingolimod 0.5 mg1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13
191Fingolimod 0.5mg1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13
192Fingolimod 1.25 mg1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13
193FINGOLIMOD HYDROCHLORIDE1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14
194Fingolimodi----1件: 13
195Fingolmod----1件: 13
196Fipamezole1件: Fipamezole---2件: 6, 17
197Fipamezole hydrochloride1件: Fipamezole---2件: 6, 17
198Fipamezole hydrochloride 30 mg oral disintegrating tablets1件: Fipamezole---2件: 6, 17
199Fipamezole hydrochloride 60 mg oral disintegrating tablets1件: Fipamezole---2件: 6, 17
200Fipamezole hydrochloride 90 mg oral disintegrating tablets1件: Fipamezole---2件: 6, 17
201Fipamezole ODT1件: Fipamezole---1件: 6
202Fipamezole ODT Cohort 21件: Fipamezole---1件: 6
203Firategrast1件: Firategrast1件: D06590 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
204Firategrast (USAN approved name)1件: Firategrast1件: D06590 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
205Firategrast 150 mg1件: Firategrast1件: D06590 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
206Firategrast 300 mg1件: Firategrast1件: D06590 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
207Firategrast gastro-retentive solution1件: Firategrast1件: D06590 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
208Firategrast immediate release tablet1件: Firategrast1件: D06590 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
209Firategrast modified release tablet1件: Firategrast1件: D06590 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
210Firdapse1件: Amifampridine1件: D10228 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 3, 11
211FIRDAPSE - 10 MG - COMPRESSE - USO ORALE - BLISTER(ALU/PVC/PVDC) 100 X 1 COMPRESSE1件: Amifampridine1件: D10228 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 3, 11
212First line DMT----1件: 13
213Fish Oil1件: Fish oil---7件: 13, 46, 49, 66, 96, 260, 299
214Fish oil concentrate1件: Fish oil---1件: 13
215Fish oil supplement1件: Fish oil---1件: 46
216Fish oil, gamma-linolenic acid3件: Fish oil,
Gamolenic acid,
alpha-Linolenic acid		1件: D07213 --1件: 46
217FISH OIL, RICH IN OMEGA-3-ACIDS2件: Fish oil,
Omega-3 fatty acids		---1件: 13
218FISH OIL,RICH IN OMEGA 3 ACIDS1件: Fish oil---1件: 13
219FITC-Adalimumab1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
220Fixed dose combination Ciprofloxacin/Celecoxib2件: Celecoxib,
Ciprofloxacin		3件: D00186 ,
D00567 ,
D02216 		1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 2
221FK-506----1件: 60
222FK506----1件: 222
223FK506 level 2-3 ng/ml----1件: 86
224FK506 level 3-5 ng/ml----1件: 86
225FK506 level < 2 ng/ml----1件: 86
226FKB327----1件: 46
227FKB327 AI----1件: 46
228FKB327 PFS----1件: 46
229Flagyl1件: Metronidazole3件: D00409 ,
D05016 ,
D05017 		--2件: 96, 97
230Flash glucose monitoring system1件: Dextrose, unspecified form---1件: 49
231Flavocoxid----1件: 113
232Flavoxate1件: Flavoxate2件: D00718 ,
D07961 		16件: PDE10A,
PDE11A,
PDE1A,
PDE1B,
PDE1C,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE7A,
PDE7B,
PDE8A,
PDE8B 💬		18件: Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
233Flaxseed1件: Flax seed---2件: 97, 299
234Flaxseed lignan-enriched complex (FLC)1件: Flax seed---1件: 97
235FLEBOGAMMA 5%----1件: 15
236Flebogamma 5% DIF----1件: 65
237Flecainide1件: Flecainide2件: D00638 ,
D07962 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6
238FLECAINIDE ACETATE2件: Acetate,
Flecainide		2件: D00638 ,
D07962 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6
239Flecainidum1件: Flecainide2件: D00638 ,
D07962 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6
240Flexible bronchoscopy in moderate sedation----1件: 84
241Flixabi1件: Infliximab1件: D02598 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
242Flolan1件: Epoprostenol2件: D00106 ,
D01337 		1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
243FLOLAN injection with currently marketed diluent1件: Epoprostenol2件: D00106 ,
D01337 		1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
244FLOLAN injection with reformulated diluent1件: Epoprostenol2件: D00106 ,
D01337 		1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
245FLOLAN TM and Glycine Diluent2件: Epoprostenol,
Glycine		3件: D00011 ,
D00106 ,
D01337 		1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
246Flolan®1件: Epoprostenol2件: D00106 ,
D01337 		1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
247FLOLAN™ and Glycine Diluent2件: Epoprostenol,
Glycine		3件: D00011 ,
D00106 ,
D01337 		1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
248FLORBETABEN (18F)1件: Florbetaben (18F)---1件: 6
249Florbetapir (18F)1件: Florbetapir (18F)---1件: 127
250Florbetapir 18F----1件: 127
251Florbetapir 18F Injection----1件: 127
252Florbetapir F 18----1件: 6
253Florence 30 µg/mL----1件: 98
254Florence 60 µg/mL----1件: 98
255Florence 90 µg/mL----1件: 98
256Flortaucipir1件: Flortaucipir1件: D11210 1件: MAPT 💬4件: Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬3件: 5, 7, 127
257Flortaucipir F181件: Flortaucipir1件: D11210 1件: MAPT 💬4件: Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬3件: 5, 7, 127
258Floseal----1件: 227
259Flovent----1件: 98
260Flow-mediated dilation of the brachial artery----1件: 49
261FLT190----1件: 19
262Flu-ATG----1件: 60
263Flucinolone acetonide----1件: 56
264FLUCLOXACILLIN1件: Flucloxacillin3件: D01249 ,
D04196 ,
D07965 		--1件: 299
265Flucloxacillin 250mg/5ml Sugar-Free Powder for Oral Solution1件: Flucloxacillin3件: D01249 ,
D04196 ,
D07965 		--1件: 299
266FLUCLOXACILLIN SODIUM1件: Flucloxacillin3件: D01249 ,
D04196 ,
D07965 		--1件: 299
267Flucloxicillin----1件: 299
268FLUCONAZOLE1件: Fluconazole2件: D00322 ,
D01429 		--2件: 96, 225
269FLUDARA1件: Fludarabine2件: D01907 ,
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬1件: 13
270Fludarabina1件: Fludarabine2件: D01907 ,
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬2件: 19, 65
271Fludarabina Accord1件: Fludarabine2件: D01907 ,
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬1件: 65
272FLUDARABINA ACCORD - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 5 FLACONCINI IN VETRO DA 2 ML1件: Fludarabine2件: D01907 ,
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬1件: 19
273FLUDARABINA FOSFATO1件: Fludarabine2件: D01907 ,
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬1件: 19
274FLUDARABINA TEVA - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 1 FLACONCINO DI VETRO DA 2 ML1件: Fludarabine2件: D01907 ,
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬1件: 65
275Fludarabine1件: Fludarabine2件: D01907 ,
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬18件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326
276Fludarabine (FLU)1件: Fludarabine2件: D01907 ,
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬2件: 60, 285
277Fludarabine monophosphate1件: Fludarabine2件: D01907 ,
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬3件: 65, 284, 326
278Fludarabine phosphate2件: Fludarabine,
Phosphate ion		2件: D01907 ,
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬12件: 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286
279Fludarabine phosphate 30 mg2件: Fludarabine,
Phosphate ion		2件: D01907 ,
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 164
280Fludarabine phosphate 40 mg2件: Fludarabine,
Phosphate ion		2件: D01907 ,
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 164
281Fludarabine, Busulfan, Thymoglobulin3件: Antithymocyte immunoglobulin (rabbit),
Busulfan,
Fludarabine		3件: D00248 ,
D01907 ,
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬1件: 65
282Fludarabine, Cyclophosphamide2件: Cyclophosphamide,
Fludarabine		4件: D00287 ,
D01907 ,
D07760 ,
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬1件: 60
283Fludarabine, Melphalan, Thiotepa3件: Fludarabine,
Melphalan,
Thiotepa		4件: D00369 ,
D00583 ,
D01907 ,
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬1件: 65
284Fludarabine/ melphalan2件: Fludarabine,
Melphalan		3件: D00369 ,
D01907 ,
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬1件: 60
285Fludarabine/busulfan2件: Busulfan,
Fludarabine		3件: D00248 ,
D01907 ,
D07966 		1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬1件: 60
286Fludeoxyglucose1件: Fludeoxyglucose (18F)---4件: 34, 84, 85, 88
287Fludeoxyglucose F 182件: Fludeoxyglucose,
Fludeoxyglucose (18F)		1件: D01843 --1件: 34
288Fludrocortisone1件: Fludrocortisone2件: D00986 ,
D07967 		1件: NR3C2 💬1件: Aldosterone-regulated sodium reabsorption 💬3件: 6, 17, 81
289Fluimucil----4件: 85, 94, 193, 298
290Fluimucil (acetylcysteine)1件: Acetylcysteine1件: D00221 --1件: 193
291FLUIMUCIL*20CPR EFF 600MG----2件: 94, 298
292Fluimucil® 600 mg effervescent tablets----1件: 85
293Flumazenil1件: Flumazenil1件: D00697 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬5件: 6, 13, 17, 18, 206
294FluMist1件: Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen---1件: 299
295Flumist®1件: Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen---1件: 299
296Fluocinolone1件: Fluocinolone---1件: 90
297Fluocinolone Acetonide2件: Fluocinolone,
Fluocinolone acetonide		1件: D01825 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 90
298Fluorescein1件: Fluorescein2件: D01261 ,
D02024 		--3件: 19, 22, 97
299Fluorescence endoscopy and spectroscopy----1件: 96
300Fluorescence Imaging----1件: 46
301Fluorescite----1件: 215
302FLUORINE (18F) FLUDEOXYGLUCOSE1件: Fludeoxyglucose1件: D01843 --2件: 84, 85
303FLUORINE-181件: Fluorine F-181件: D05860 --1件: 41
304Fluorodeoxyglucose----1件: 84
305Fluoroscopic swallow evaluation----1件: 6
306Fluoxetin1件: Fluoxetine2件: D00326 ,
D00823 		1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬3件: 13, 179, 206
307Fluoxetin Hexal1件: Fluoxetine2件: D00326 ,
D00823 		1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 13
308FLUOXETINE1件: Fluoxetine2件: D00326 ,
D00823 		1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬4件: 13, 17, 78, 86
309FLUOXETINE HYDROCHLORIDE1件: Fluoxetine2件: D00326 ,
D00823 		1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 13
310Fluoxétine1件: Fluoxetine2件: D00326 ,
D00823 		1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 17
311Flupentixol1件: Flupentixol1件: D01044 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 97
312Flupirtin----1件: 13
313Flupirtine1件: Flupirtine1件: D07978 --1件: 13
314Flupirtinmaleat----1件: 13
315FLURBIPROFEN1件: Flurbiprofen3件: D00330 ,
D01475 ,
D02290 		2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬3件: 13, 21, 46
316Flutamide1件: Flutamide1件: D00586 1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 81
317Flutemetamol1件: Flutemetamol (18F)---5件: 5, 6, 7, 17, 127
318Flutemetamol F182件: Flutemetamol,
Flutemetamol (18F)		---5件: 5, 6, 7, 17, 127
319Fluticasone1件: Fluticasone1件: D07981 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 98, 228, 299
320Fluticasone MDI1件: Fluticasone1件: D07981 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98
321FLUTICASONE PROPIONATE2件: Fluticasone,
Fluticasone propionate		2件: D01708 ,
D07981 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 98, 228
322Fluticasone Propionate, 800 mcg twice daily (post 4FED failure)2件: Fluticasone,
Fluticasone propionate		2件: D01708 ,
D07981 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98
323Fluticasone Propionate, 880 mcg twice daily (after 6FED failure)1件: Fluticasone propionate1件: D01708 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98
324Fluticasone Propionate, USP2件: Fluticasone,
Fluticasone propionate		2件: D01708 ,
D07981 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98
325Fluvastatin1件: Fluvastatin2件: D00892 ,
D07983 		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬3件: 79, 218, 222
326Fluzone1件: Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated)---2件: 21, 49
327Fluzone®1件: Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated)---1件: 21
328FLX-787-ODT----1件: 2
329FLX-787-ODT (orally disintegrating tablet)----1件: 10
330FLX-787-ODT (orally disintigrating tablet)----1件: 2
331FMP-30----1件: 53
332FMP30 Donor Stool----1件: 13
333FMT----2件: 96, 97
334FMT enema----1件: 97
335FMT infusions----1件: 97
336FMT oral----1件: 97
337FMT+MTX----1件: 46
338Focetria----1件: 46
339Focetria (Monovalent MF59-Adjuvanted vaccine)----3件: 46, 49, 271
340Folate1件: Folic acid1件: D00070 --4件: 13, 41, 46, 49
341FolateScan (Technetium Tc 99mEC20)----4件: 13, 46, 49, 96
342Folic (or folinic) acid----2件: 46, 256
343Folic acid1件: Folic acid1件: D00070 --4件: 6, 46, 49, 84
344Folic acid or folate1件: Folic acid1件: D00070 --1件: 46
345Folic Acid, Vitamin B6, Vitamin B123件: Cyanocobalamin,
Folic acid,
Pyridoxine		7件: D00070 ,
D00166 ,
D02179 ,
D03615 ,
D03616 ,
D03617 ,
D08454 		--1件: 6
346Folic/folinic acid1件: Leucovorin3件: D01211 ,
D07986 ,
D07987 		--2件: 46, 107
347Foliglurax1件: Foliglurax---1件: 6
348Foliglurax 10 mg (treatment A)1件: Foliglurax---1件: 6
349Foliglurax 30 mg (treatment B)1件: Foliglurax---1件: 6
350Folimet----1件: 46
351Folinic acid1件: Leucovorin3件: D01211 ,
D07986 ,
D07987 		--3件: 46, 107, 320
352Follow-up probiotic----1件: 193
353Follow-up study of the treated cohort----1件: 193
354Fontolizumab1件: Fontolizumab1件: D04242 1件: IFNG 💬32件: African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 46
355Foralumab1件: Foralumab---2件: 13, 96
356Forigerimod1件: Forigerimod1件: D09904 --1件: 49
357FORLAX 4 g, poudre pour solution buvable en sachet----1件: 299
358Formalin1件: Formaldehyde1件: D00017 --1件: 84
359Formistin----1件: 13
360FORMISTIN - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE----1件: 13
361Formistin 10 mg----1件: 13
362Formoterol1件: Formoterol3件: D01373 ,
D05277 ,
D07990 		1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 85, 228, 299
363Formoterol fumarate dihydrate1件: Formoterol3件: D01373 ,
D05277 ,
D07990 		1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 85
364Formoterol/Budesonide2件: Budesonide,
Formoterol		4件: D00246 ,
D01373 ,
D05277 ,
D07990 		2件: ADRB2,
NR3C1 💬		9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 228
365Formulation A----1件: 13
366Formulation B----1件: 13
367Formulation C----1件: 13
368Formulation D----1件: 13
369Forsteo1件: Teriparatide1件: D06078 1件: PTH1R 💬3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬3件: 70, 235, 274
370FORSTEO-R1件: Teriparatide1件: D06078 1件: PTH1R 💬3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235
371FORTECORTIN----2件: 28, 65
372Fortecortin Inject 40 mg Amp.----1件: 65
373Forteo1件: Teriparatide1件: D06078 1件: PTH1R 💬3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 70
374Fortum----1件: 299
375FOS----2件: 66, 96
376Foscarbidopa1件: Foscarbidopa1件: D12057 --1件: 6
377Foscarbidopa and Foslevodopa2件: Foscarbidopa,
Foslevodopa		2件: D11839 ,
D12057 		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
378Foscarnet1件: Foscarnet2件: D00579 ,
D02267 		--2件: 28, 60
379Foscarnet sodium1件: Foscarnet2件: D00579 ,
D02267 		--2件: 28, 60
380FosD----1件: 46
381Fosfamatinib Disodium----1件: 46
382Fosfato sodico de dexametasona1件: Dexamethasone9件: D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 96
383Fosfomycin1件: Fosfomycin4件: D00925 ,
D02187 ,
D02188 ,
D04253 		--2件: 96, 97
384FOSFOMYCIN DISODIUM1件: Fosfomycin4件: D00925 ,
D02187 ,
D02188 ,
D04253 		--1件: 97
385Foslevodopa1件: Foslevodopa1件: D11839 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
386Fosmetpantotenate----1件: 120
387Fosmetpantotenate (RE-024)----1件: 120
388FOSMETPANTOTENATE DRUG SUBSTANCE----1件: 120
389Fosmetpantotenato----1件: 120
390Fospropofol1件: Fospropofol---1件: 226
391Fospropofol (Lusedra®) 101件: Fospropofol---1件: 226
392Fospropofol (Lusedra®) 121件: Fospropofol---1件: 226
393Fospropofol (Lusedra®) 6.51件: Fospropofol---1件: 226
394Fostair----1件: 85
395Fostamatinib1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬4件: 46, 49, 61, 66
396Fostamatinib 100 mg1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66
397Fostamatinib 100 mg tablet1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66
398Fostamatinib 150 mg1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66
399Fostamatinib 150 mg bid1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 61
400Fostamatinib 150 mg tablet1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66
401Fostamatinib 50 mg blue film-coated tablet1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 46
402Fostamatinib Disodium1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬3件: 46, 61, 66
403Fostamatinib Disodium (R935788)1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬2件: 46, 49
404Fostamatinib Disodium tablet 100 mg1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66
405Fostamatinib Disodium tablet 150 mg1件: Fostamatinib1件: D09347 1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66
406Four-point cane (FPC)----1件: 13
407Fourier Domain Doppler Optical Coherence Tomography (FDOCT)----1件: 13
408FP-045----1件: 285
409FP-110----1件: 97
410FP-CYA-050----1件: 97
411FP-CYA-053----1件: 97
412FPA008----1件: 46
413FPC----1件: 13
414FPF 300 (thalidomide)1件: Thalidomide1件: D00754 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 16
415FPF1011----1件: 263
416FPF1100NW----1件: 6
417FPFS-1169----1件: 6
418FR104----1件: 46
419Fractional carbon dioxide laser2件: Activated charcoal,
Carbon dioxide		1件: D00004 --1件: 51
420Fractionated Carbon Dioxide (FCO2) Laser2件: Activated charcoal,
Carbon dioxide		1件: D00004 --1件: 50
421Fragmin1件: Dalteparin---1件: 222
422Free amino acids intake1件: Amino acids---1件: 240
423Freeze-dried black raspberry powder1件: Raspberry1件: D09179 --1件: 97
424Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS)1件: Human immunoglobulin G---3件: 14, 43, 45
425Fremanezumab1件: Fremanezumab1件: D11055 1件: CALCA 💬2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬2件: 124, 226
426Frequently Sampled Oral Glucose Tolerance Test and CGM1件: Dextrose, unspecified form---1件: 299
427Fresenius-Kabi)----1件: 46
428Fresh Frozen Plasma----1件: 5
429Fresolimumab1件: Fresolimumab1件: D09620 3件: TGFB1,
TGFB2,
TGFB3 💬		35件: AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬3件: 51, 222, 274
430Frisium----1件: 140
431FRISIUM*30CPS 10MG----1件: 140
432FRM-0334----1件: 127
433From August 2020 'no additional treatment'----1件: 51
434FSME-IMMUN----1件: 46
435FT011----1件: 51
436FT011 100 mg----1件: 51
437FT011 200 mg----1件: 51
438FTI, AZLI----1件: 299
439FTX-1821----1件: 113
440FTY720----2件: 13, 14
441FTY720D----1件: 13
442FTY720I----1件: 14
443Fucidin1件: Fusidic acid1件: D04281 --1件: 299
444Fucidin Tablets1件: Fusidic acid1件: D04281 --1件: 299
445Fucose1件: Fucose---1件: 65
446Full Spectrum vitamin----1件: 13
447Fully human anti-interferon gamma monoclonal antibody1件: Interferon Gamma---1件: 107
448Fully human IgG2 lambda monoclonal antibody----1件: 172
449Fully human monoclonal antibody directed against CXCL10----1件: 93
450Fully humanised, recombinant monoclonal antibody (IgG1)----1件: 96
451Fully humanized anti-human IL-6 receptor (IL-6R) neutralizing monoclonal antibody----1件: 13
452Fultium-D3 800IU capsules----1件: 274
453Fulvestrant1件: Fulvestrant1件: D01161 2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 86
454Fumaderm----1件: 49
455Fumaderm®----1件: 49
456Fumaderm® initial----1件: 49
457Fumaric acid1件: Fumaric acid1件: D02308 --1件: 13
458Functional hepatic nitrogen clearance1件: Nitrogen1件: D00083 --1件: 171
459Functional Magnetic Resonance Imaging----1件: 6
460FURESTEM-RA Inj----1件: 46
461FURESTEM-RA Inj.----1件: 46
462Furosemide1件: Furosemide1件: D00331 1件: SLC12A2 💬3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬1件: 6
463Furosemide Injection1件: Furosemide1件: D00331 1件: SLC12A2 💬3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬1件: 6
464FUSIDIC ACID1件: Fusidic acid1件: D04281 --1件: 299
465Fusidin----1件: 299
466Fusion1件: Iron polymaltose---7件: 11, 13, 46, 49, 69, 70, 271
467Fuzhenghuayu----1件: 93
468Fx-1006A1件: Fx-1006A---1件: 28
469FX125L----1件: 46
470FXIII Concentrate (Human)----1件: 288
471FXIII Concentrate (Human) (FXIII)----1件: 288
472Fycompa1件: Perampanel1件: D08964 4件: GRIA1,
GRIA2,
GRIA3,
GRIA4 💬		16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬2件: 2, 144